361 CAPITAL LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q2 2020$621,000
-76.9%
16,873
-64.0%
0.29%
-37.6%
Q1 2019$2,686,000
+50.3%
46,861
+10.0%
0.47%
+27.7%
Q4 2018$1,787,000
-5.4%
42,604
+70.3%
0.36%
-11.0%
Q3 2018$1,889,000
+5.6%
25,022
+0.4%
0.41%
+1.2%
Q2 2018$1,788,00024,9150.40%
Other shareholders
REGENXBIO INC shareholders Q1 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 831,014$15,714,4756.51%
MPM BioImpact LLC 617,671$11,680,1593.03%
Sonic GP LLC 193,079$3,651,1242.79%
ArchPoint Investors 224,278$4,241,0971.84%
Redmile Group, LLC 1,640,725$31,026,1101.35%
MIRABELLA FINANCIAL SERVICES LLP 25,983$5,461,3440.83%
WS MANAGEMENT LLLP 396,997$7,507,2130.79%
Redwood Wealth Management Group, LLC 15,190$287,2430.33%
SummerHaven Investment Management, LLC 27,503$520,0820.30%
Lombard Odier Asset Management (Switzerland) SA 130,369$2,465,2780.22%
View complete list of REGENXBIO INC shareholders